Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
December-2018 Volume 16 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2018 Volume 16 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Berberine alleviates amyloid β25‑35‑induced inflammatory response in human neuroblastoma cells by inhibiting proinflammatory factors

  • Authors:
    • Jing Xu
    • Wenlan Wu
    • Hong Zhang
    • Li Yang
  • View Affiliations / Copyright

    Affiliations: Department of Geriatrics, The Affiliated Drum Tower Hospital of Medical School of Nanjing University, Nanjing, Jiangsu 210008, P.R. China, Department of Head and Neck Surgery, Jiangsu Cancer Hospital, Nanjing, Jiangsu 210008, P.R. China
  • Pages: 4865-4872
    |
    Published online on: September 17, 2018
       https://doi.org/10.3892/etm.2018.6749
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The present study investigated the effect of berberine (BBR) on amyloid β 25‑35 (Aβ25‑35)‑induced inflammatory response in human neuroblastoma cells. To model the inflammatory response observed in the central nervous system of patients with Alzheimer's disease, SH‑SY5Y and SK‑N‑SH neuroblastoma cells were induced by Aβ25‑35 (5 µM) for 24 h. Subsequently, cells were treated with BBR or indomethacin for 2 h. The cell survival rate was determined by the MTT assay. The activity of lactate dehydrogenase (LDH) in the cell culture medium was examined by spectrophotometry. The expression levels of inflammatory factors prostaglandin E2 (PGE2) and tumor necrosis factor‑α (TNF‑α) were determined by ELISA assays. The mRNA and protein expression levels of interleukin (IL)‑1β, cyclooxygenase 2 (COX‑2) and tumor necrosis factor receptor 1 (TNFR1) were measured by reverse‑transcription‑quantitative polymerase chain reaction and Western blotting, respectively. The results indicated that, treatment with Aβ25‑35 increased the expression levels of PGE2 and TNF‑α, increased the activity of LDH, and up‑regulated the mRNA and protein expression of COX‑2, IL‑1β, and TNFR1. Treatment with BBR down‑regulated the expression levels of PGE2 and TNF‑α, decreased the activity of LDH, and downregulated the mRNA and protein expression of COX‑2, IL‑1β, and TNFR1. Taken together, the present results suggested that BBR suppressed the inflammatory response induced by Aβ25‑35 in neuroblastoma cells. The mechanism of action may be associated with the inhibition of proinflammatory factors.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Chen HZ, Lin GW and Wang JY: Practice of Internal Medicine. 14th. People's Medical Publishing House; Beijing: 2017, View Article : Google Scholar

2 

Breitner JC: NSAIDs and Alzheimer's disease: How far to generalize from trials? Lancet Neurol. 2:5272003. View Article : Google Scholar : PubMed/NCBI

3 

Hung CW, Chen YC, Hsieh WL, Chiou SH and Kao CL: Ageing and neurodegenerative diseases. Ageing Res Rev. 9 Suppl 1:S36–S46. 2010. View Article : Google Scholar : PubMed/NCBI

4 

Tang J, Feng Y, Tsao S, Wang N, Curtain R and Wang Y: Berberine and Coptidis Rhizoma as novel antineoplastic agents: A review of traditional use and biomedical investigations. J Ethnopharmacol. 126:5–17. 2009. View Article : Google Scholar : PubMed/NCBI

5 

Xiang W, Huang XJ and Huang GX: Study of two anti-flammatory drugs treating primary type 2 diabetic. J Pract Diabetes. 7:51–52. 2011.

6 

Kearse M, Moir R, Wilson A, Stones-Havas S, Cheung M, Sturrock S, Buxton S, Cooper A, Markowitz S, Duran C, et al: Geneious basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics. 28:1647–1649. 2012. View Article : Google Scholar : PubMed/NCBI

7 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

8 

Halliday G, Robinson SR, Shepherd C and Kril J: Alzheimer's disease and inflammation: A review of cellular and therapeutic mechanisms. Clin Exp Pharmacol Physiol. 27:1–8. 2000. View Article : Google Scholar : PubMed/NCBI

9 

Zamolodchikov D and Strickland S: A possible new role for Aβ in vascular and inflammatory dysfunction in Alzheimer's disease. Thromb Res. 141 Suppl 2:S59–S61. 2016. View Article : Google Scholar : PubMed/NCBI

10 

Hurtado DE, Molina-Porcel L, Iba M, Aboagye AK, Paul SM, Trojanowski JQ and Lee VM: A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an alzheimer mouse model. Am J Pathol. 177:1977–1988. 2010. View Article : Google Scholar : PubMed/NCBI

11 

Ringheim GE, Szczepanik AM, Petko W, Burgher KL, Zhu SZ and Chao CC: Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/interleukin-6 complex. Brain Res Mol Brain Res. 55:35–44. 1998. View Article : Google Scholar : PubMed/NCBI

12 

Li Y, Liu L, Kang J, Sheng JG, Barger SW, Mrak RE and Griffin WS: Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. J Neurosci. 20:149–155. 2000. View Article : Google Scholar : PubMed/NCBI

13 

Sheng JG, Zhu SG, Jones RA, Griffin WS and Mrak RE: Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo. Exp Neurol. 163:388–391. 2000. View Article : Google Scholar : PubMed/NCBI

14 

Farooqui AA: Chapter 6: Contribution of neuroinflammation in the pathogenesis of Alzheimer's disease. Neurochemical Aspects of Alzheimer's DiseaseRisk Factors, Pathogenesis, Biomarkers, and Potential Treatment Strategies. Academic Press; pp. 201–245. 2017

15 

Pollak TA, Drndarski S, Stone JM, David AS, McGuire P and Abbott NJ: The blood-brain barrier in psychosis. Lancet Psychiatry. 5:79–92. 2018. View Article : Google Scholar : PubMed/NCBI

16 

Zhi-you C and Yong Y: Pathway and mechanism of oxidative stress in Alzheimer's disease. J Med Coll PLA. 22:320–324. 2007. View Article : Google Scholar

17 

Teeling JL and Perry VH: Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: Underlying mechanisms. Neuroscience. 158:1062–1073. 2009. View Article : Google Scholar : PubMed/NCBI

18 

Giovannini MG, Scali C, Prosperi C, Bellucci A, Vannucchi MG, Rosi S, Pepeu G and Casamenti F: Beta-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: Involvement of the p38MAPK pathway. Neurobiol Dis. 11:257–274. 2002. View Article : Google Scholar : PubMed/NCBI

19 

Wang X, Wang R, Xing D, Su H, Ma C, Ding Y and Du L: Kinetic difference of berberine between hippocampus and plasma in rat after intravenous administration of Coptidis rhizoma extract. Life Sci. 77:3058–3067. 2005. View Article : Google Scholar : PubMed/NCBI

20 

Kulkarni SK and Dhir A: Berberine: A plant alkaloid with therapeutic potential for central nervous system disorders. Phytother Res. 24:317–324. 2010. View Article : Google Scholar : PubMed/NCBI

21 

Liu BZ, Zhang J and Yang JQ: The protective effect and mechanism of Berberine on chronic brain injury in mice induced by aluminum overload. Chin Herbal Med. 39:1351–1355. 2008.(In Chinese).

22 

Lukiw WJ, Percy ME and Kruck TP: Nanomolar aluminum induces pro-inflammatory and pro-apoptotic gene expression in human brain cells in primary culture. J Inorg Biochem. 99:1895–1898. 2005. View Article : Google Scholar : PubMed/NCBI

23 

Babcock AA, Ilkjær L, Clausen BH, Villadsen B, Dissing-Olesen L, Bendixen AT, Lyck L, Lambertsen KL and Finsen B: Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice. Brain Behav Immun. 48:86–101. 2015. View Article : Google Scholar : PubMed/NCBI

24 

Nie YH: Regulation of Interleukin-1 on β-amyloid cytotoxic and gene expression. Chin Clin Rehabilitat. 8:79–81. 2004.

25 

Tseng WY, Huang YS, Lin HH, Luo SF, McCann F, McNamee K, Clanchy F and Williams R: TNFR signaling and its clinical implications. Cytokine. 101:19–25. 2018. View Article : Google Scholar

26 

Mayhan WG: Cellular mechanisms by which tumor necrosis factor-alpha produces disruption of the blood-brain barrier. Brain Res. 927:144–152. 2002. View Article : Google Scholar : PubMed/NCBI

27 

Keller C, Keller P, Giralt M, Hidalgo J and Pedersen BK: Exercise normalises overexpression of TNF-alpha in knockout mice. Biochem Biophys Res Commun. 321:179–182. 2004. View Article : Google Scholar : PubMed/NCBI

28 

Toda K, Hayashi Y and Saibara T: Deletion of tumor necrosis factor-alpha receptor type 1 exacerbates insulin resistance and hepatic steatosis in aromatase knockout mice. Biochim Biophys Acta. 1801:655–664. 2010. View Article : Google Scholar : PubMed/NCBI

29 

Mizoguchi E, Hachiya Y, Kawada M, Nagatani K, Ogawa A, Sugimoto K, Mizoguchi A and Podolsky DK: TNF receptor type I-dependent activation of innate responses to reduce intestinal damage-associated mortality. Gastroenterology. 134:470–480. 2008. View Article : Google Scholar : PubMed/NCBI

30 

Schmidt N, Haydn T, Schneider I, Busch H, Boerries M and Fulda S: Smac mimetic induces an early wave of gene expression via NF-κB and AP-1 and a second wave via TNFR1 signaling. Cancer Lett. 421:170–185. 2018. View Article : Google Scholar : PubMed/NCBI

31 

Vilela MC, Lima GK, Rodrigues DH, Lacerda-Queiroz N, Mansur DS, de Miranda AS, Rachid MA, Kroon EG, Vieira LQ, Campos MA, et al: TNFR1 plays a critical role in the control of severe HSV-1 encephalitis. Neurosci Lett. 479:58–62. 2010. View Article : Google Scholar : PubMed/NCBI

32 

Huang LX, Yin BJ and Wang J: Sealing action of TNFRI blocking peptide-hIgGFc fusion protein and TNFRI blocking peptide on the biological effect induced by TNF-α. Chin J Immunol. 24:776–780. 2008.

33 

Stanimirovic D, Shapiro A, Wong J, Hutchison J and Durkin J: The induction of ICAM-1 in human cerebromicrovascular endothelial cells (HCEC) by ischemia-like conditions promotes enhanced neutrophil/HCEC adhesion. J Neuroimmunol. 76:193–205. 1997. View Article : Google Scholar : PubMed/NCBI

34 

Candelario-Jalil E, González-Falcón A, García-Cabrera M, León OS and Fiebich BL: Post-ischaemic treatment with the cyclooxygenase-2 inhibitor nimesulide reduces blood-brain barrier disruption and leukocyte infiltration following transient focal cerebral ischaemia in rats. J Neurochem. 100:1108–1120. 2007. View Article : Google Scholar : PubMed/NCBI

35 

Takadera T and Ohyashiki T: Prostaglandin E2 deteriorates N-methyl-D-aspartate receptor-mediated cytotoxicity possibly by activating EP2 receptors in cultured cortical neurons. Life Sci. 78:1878–1883. 2006. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Xu J, Wu W, Zhang H and Yang L: Berberine alleviates amyloid β25‑35‑induced inflammatory response in human neuroblastoma cells by inhibiting proinflammatory factors. Exp Ther Med 16: 4865-4872, 2018.
APA
Xu, J., Wu, W., Zhang, H., & Yang, L. (2018). Berberine alleviates amyloid β25‑35‑induced inflammatory response in human neuroblastoma cells by inhibiting proinflammatory factors. Experimental and Therapeutic Medicine, 16, 4865-4872. https://doi.org/10.3892/etm.2018.6749
MLA
Xu, J., Wu, W., Zhang, H., Yang, L."Berberine alleviates amyloid β25‑35‑induced inflammatory response in human neuroblastoma cells by inhibiting proinflammatory factors". Experimental and Therapeutic Medicine 16.6 (2018): 4865-4872.
Chicago
Xu, J., Wu, W., Zhang, H., Yang, L."Berberine alleviates amyloid β25‑35‑induced inflammatory response in human neuroblastoma cells by inhibiting proinflammatory factors". Experimental and Therapeutic Medicine 16, no. 6 (2018): 4865-4872. https://doi.org/10.3892/etm.2018.6749
Copy and paste a formatted citation
x
Spandidos Publications style
Xu J, Wu W, Zhang H and Yang L: Berberine alleviates amyloid β25‑35‑induced inflammatory response in human neuroblastoma cells by inhibiting proinflammatory factors. Exp Ther Med 16: 4865-4872, 2018.
APA
Xu, J., Wu, W., Zhang, H., & Yang, L. (2018). Berberine alleviates amyloid β25‑35‑induced inflammatory response in human neuroblastoma cells by inhibiting proinflammatory factors. Experimental and Therapeutic Medicine, 16, 4865-4872. https://doi.org/10.3892/etm.2018.6749
MLA
Xu, J., Wu, W., Zhang, H., Yang, L."Berberine alleviates amyloid β25‑35‑induced inflammatory response in human neuroblastoma cells by inhibiting proinflammatory factors". Experimental and Therapeutic Medicine 16.6 (2018): 4865-4872.
Chicago
Xu, J., Wu, W., Zhang, H., Yang, L."Berberine alleviates amyloid β25‑35‑induced inflammatory response in human neuroblastoma cells by inhibiting proinflammatory factors". Experimental and Therapeutic Medicine 16, no. 6 (2018): 4865-4872. https://doi.org/10.3892/etm.2018.6749
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team